Multimodal Neuroimaging of Stress and Reward Cues to Assess Alcoholism Risk and Relapse

NACompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Alcohol Dependence
Interventions
DEVICE

Multi-method Neuroendocrine and Neuroimaging Procedure Scan 1

The MRI scan will be conducted on a 3-T Siemens Trio MRI system equipped with a standard quadrature head coil, using T1 MPRAGE sequence for structural scanning and T2\*-sensitive gradient-recalled single shot echo planar pulse sequence for functional scans. Two multimethod MRI scans will be conducted in the AD sample, while the controls will participate in a single scan.

DEVICE

Multi-method Neuroendocrine and Neuroimaging Procedure Scan 2

The MRI scan will be conducted on a 3-T Siemens Trio MRI system equipped with a standard quadrature head coil, using T1 MPRAGE sequence for structural scanning and T2\*-sensitive gradient-recalled single shot echo planar pulse sequence for functional scans. Two multimethod MRI scans will be conducted in the AD sample, while the controls will participate in a single scan.

Trial Locations (1)

06519

Yale Stress Center, New Haven

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER

NCT02616094 - Multimodal Neuroimaging of Stress and Reward Cues to Assess Alcoholism Risk and Relapse | Biotech Hunter | Biotech Hunter